---
document_datetime: 2023-09-21 21:57:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/constella-epar-all-authorised-presentations_en.pdf
document_name: constella-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7095653
conversion_datetime: 2025-12-20 19:00:25.273593
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                                  | (Invented) name                         | Strength                    | Pharmaceutical Form                                     | Route of Administration             | Immediate Packaging                                     | Pack size                                                             |
|-----------------------------------------------------------------|-----------------------------------------|-----------------------------|---------------------------------------------------------|-------------------------------------|---------------------------------------------------------|-----------------------------------------------------------------------|
| EU/1/12/801/001 EU/1/12/801/002 EU/1/12/801/004 EU/1/12/801/005 | Constella Constella Constella Constella | 290 µg 290 µg 290 µg 290 µg | Capsule, hard Capsule, hard Capsule, hard Capsule, hard | Oral use Oral use Oral use Oral use | bottle (HDPE) bottle (HDPE) bottle (HDPE) bottle (HDPE) | 10 capsules 28 capsules 90 capsules 112 (4 x 28) capsules (multipack) |